Cogent Biosciences Inc. (COGT)
undefined
undefined%
At close: undefined
8.15
-0.85%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue - - - 7.87M 22.50M 9.73M 8.36M 6.36M 2.99M
Cost of Revenue 3.59M 5.88M 147.00K 25.74K 43.71K - - - -
Gross Profit -3.59M -5.88M -147.00K 7.85M 22.46M 9.73M 8.36M 6.36M 2.99M
Operating Income -208.13M -147.84M -75.55M -82.20M -32.18M -36.01M -26.15M -19.07M -6.59M
Interest Income 13.08M 3.99M 467.00K 144.00K 267.00K 1.15M 386.00K 265.00K -
Pretax Income -192.41M -140.24M -72.27M -74.81M -31.83M -34.53M -25.49M -18.12M -6.59M
Net Income -192.41M -132.64M -71.81M -66.45M -30.27M -34.53M -25.49M -18.12M -6.59M
Selling & General & Admin 34.38M 26.21M 19.64M 17.42M 10.97M 7.45M 4.68M 3.43M 2.73M
Research & Development 173.75M 121.63M 55.91M 72.65M 43.71M 38.28M 29.83M 21.99M 6.85M
Other Expenses - 3.61M 2.81M -246.00K 78.00K 320.00K 274.00K 681.00K -
Operating Expenses 208.13M 147.84M 75.55M 90.07M 54.68M 45.74M 34.51M 25.43M 9.58M
Interest Expense - 3.99M - - - - - - -
Selling & Marketing Expenses - - - - - - - - -
Cost & Expenses 208.13M 147.84M 75.55M 90.07M 54.68M 45.74M 34.51M 25.43M 9.58M
Income Tax - -7.60M -467.00K -8.36M -1.56M 1.47M -386.00K -265.00K -
Shares Outstanding (Basic) 79.66M 58.74M 38.73M 11.08M 7.62M 6.22M 7.40M 5.86M 5.86M
Shares Outstanding (Diluted) 79.66M 58.74M 38.73M 11.08M 7.62M 6.22M 7.40M 7.40M 7.40M
EPS (Basic) -2.42 -2.26 -1.85 -6 -3.97 -5.55 -3.45 -3.1 -1.13
EPS (Diluted) -2.42 -2.26 -1.85 -6 -3.97 -5.55 -3.45 -2.45 -0.89
EBITDA -205.86M -134.36M -75.40M -34.57M -30.89M -34.68M -24.98M -18.24M -6.41M
Depreciation & Amortization 2.27M 5.88M 147.00K 720.00K 1.29M 1.32M 1.17M 830.00K 179.00K